Skip to main content

The Academy’s Century-Long History with Solar Energy

Solar panels with the shining sun in the background.

What started as novel research 100 years ago is a major source of energy today, in part because of a research prize established by an Academy member.

Published July 30, 2024

By Nick Fetty
Digital Content Manager

Abraham Cressy Morrison/Public Domain

While electric vehicles and solar panels are commonplace around New York these days, the city’s history with solar energy goes back at least a century.

The New York Academy of Sciences has been an incubator for solar energy research and promotion since the early part of the 20th century. This is when Academy member Abraham Cressy Morrison established “a prize of $100 (the equivalent of about $1,800 today) for the best paper on the question of whether released intra-atomic energy constitutes an important source of solar and stellar energy,” according to reporting from The New York Times.

Morrison, who served as the Academy’s President from 1938 to 1939, funded various awards and prizes promoting scientific research in the first half of the 20th century.

The Early Days of Solar Energy

While solar energy research was novel at the time the award was established, within five years researchers were making advancements that helped to prove the potential of this new energy source. “This is merely an indication of the speed with which scientific research makes progress today,” The Brooklyn Daily Eagle reported in 1929.

According to that same article, Morrison pushed back at the idea that his motives were commercial, and instead emphasized his desire to advance science for sciences’ sake.

“It is of much more interest to me to know how the sun creates and continues its energy,” Morrison was quoted. “There is a gap in our knowledge of the sun and throughout the heavens there is a question mark that challenges us.”

Morrison was not the only scientist from this era to see solar as a potential energy source. The sentiment was shared by Thomas Edison, who happened to be a Fellow of the Academy. Around this time, the title of “Fellow” was bestowed upon active resident members credited with significant scientific achievements.

In a 1929 interview with Forbes magazine, Edison was asked “Do you believe that the age of electrical invention and discovery is over?” The 86-year-old Edison responded simply, “No; just started.”

Later in the interview he was asked “Do you believe the time will come when the world petroleum supply will be exhausted and man will turn to electric vehicles?” But oddly enough, he didn’t quite yet see the potential in EVs, answering “If petroleum was exhausted, we can get power for automobiles from powered coal, benzol, alcohol.”

Research Published in Annals and Transactions

The research that resulted from Morrison’s prizes would go on to be published in Annals of the New York Academy of Sciences, the Academy’s academic journal that dates back to 1823.

Volume XLII, Article 2 of Annals, published in 1941, focused on “The Fundamental Properties of the Galactic System.”  Academic papers published in this issue examined topics like “The Luminosity Function” and “The Stellar Distribution of High and Intermediate Latitudes.”

The issue also acknowledged Morrison directly, stating “This publication is due to the generosity of Mr. A. Cressy Morrison, who, through the establishment of the A. Cressy Morrison series of prizes in astronomy, has stimulated many noteworthy investigations on the sources of stellar energy.”

The Academy also devoted entire conferences to this line of research during this era. An astronomical conference in 1939, entitled “The Internal Constitution of the Stars,” brought in presenters from as far away as Finland and Czechoslovakia. The conference was so well-received that “[i]t was unanimously decided to follow up this meeting with a second conference to be held next fall,” according to Transactions of the New York Academy of Sciences.

Academy Awards Support Solar Energy (2018-2021)

Solar energy continues to be part of the Academy’s programming today from Awards to Education. Several recent recipients of the Blavatnik Awards for Young Scientists, sponsored by the Blavatnik Family Foundation and administered by the Academy, have made significant scientific research contributions to the field.

Henry Snaith, the 2018 Blavatnik Awards in the United Kingdom Physical Sciences & Engineering Laureate and who serves as the Binks Professor of Renewable Energy at the University of Oxford, found that metal halide perovskite materials can be employed in highly efficient solar cells. Snaith’s research aims to significantly reduce costs for “photovoltaic solar power [which] could help propel society to a sustainable future.”

Xiaoming Zhao, the 2021 Blavatnik Regional Awards Finalist in Chemistry and now on the faculty at Nanjing University of Aeronautics and Astronautics, has conducted extensive research on “perovskites,” which are less expensive and easier to produce than silicon-based solar cells. His research found “record-breaking efficiency and high stability after long-term use.”

Daniel Straus, the 2021 Blavatnik Regional Awards Winner in Chemistry and an assistant professor of chemistry at Tulane University, has advanced solar cells in two ways as a materials chemist. First, he “identified a structural instability in a promising new solar cell material, known as cesium lead iodide,” then he “also demonstrated a new technique to make chiral, or asymmetric, materials from very simple non-chiral molecules.”

Academy Awards Support Solar Energy (2022-2024)

Menny Shalom, the 2022 Blavatnik Awards in Israel Laureate in Chemistry and a professor of chemistry at Ben-Gurion University of the Negev, is developing stable, low-cost materials that “can be utilized for applications in photocatalytic and photo-electrochemical reactions and the development of solar cells, batteries, and fuel cells.”

Svitlana Mayboroda, the 2023  Blavatnik National Awards Physical Sciences & Engineering Laureate and McKnight Presidential Professor of Mathematics at the University of Minnesota, conducts research that provides “physicists with a new fundamental understanding of matter yielding improvements in crucial 21st century technologies, including LED lighting, semiconductors, and solar cells.”

Jooho Lee, the 2023 Blavatnik Regional Awards Laureate in Chemistry and an assistant professor of chemistry and chemical biology at Harvard University, studies “emergent functional materials, including solar cells, electrocatalysts for the hydrogen economy, and optoelectronics” at the microscale.

Samuel D. Stranks, the 2024 Blavatnik Awards in the United Kingdom Chemical Sciences Finalist and a professor of optoelectronics at the University of Cambridge, conducts research to make perovskite solar cells more commercially viable. His “work particularly sheds light on where efficiency losses are in perovskite materials and how they degrade over time, providing critical guidance to engineer long-lasting and high-performing commercial solar cells.”

Academy Educational Initiatives Advance Solar Energy

Renewable energy, specifically solar, was a component in the Junior Academy’s spring 2022 innovation challenge, sponsored by Ericsson. The winning team suggested utilizing solar panels as an energy source for their smart home concept.

Junior Academy member Sthuthi S. wanted to develop a solar panel that wouldn’t negatively impact wild birds. She and her team suggested using “infrared sensors and speakers [that produce] beeping noises at 3 kHz [to] deter birds from landing on solar panels.”

Fellow Junior Academy member Sharon L. expressed her optimism about future advancements in solar energy. “Finally, the development of new renewable energy sources — from paint-on solar cells to microgrids — are soon going to provide a democratization of energy to all corners of the world,” she said in 2017 for an article examining the next 100 years of scientific achievement. “It’s incredibly exciting to be living in a generation where we’ll have the opportunity to contribute to such innovative research!”

According to data from the Solar Energy Industries Association, cumulative U.S. solar installations went from less than 20,000 installed solar capacity (MWdc) in 2010, to nearly 200,000 MWdc in 2024. Similarly, data from the International Energy Agency shows that battery electric vehicles and plug-in hybrid vehicles in the U.S. rose from roughly 200,000 in 2013 to 4.8 million in 2023.

The Academy is at the forefront of new budding solar energy technologies that will help power the future. So, next time you see an EV driving down Broadway, or an array of solar panels on a rooftop, remember that technology has been a work in progress for at least a century. And the Academy has played its role in leading the “charge.”

Len Blavatnik

A man smiles for the camera.

Founder
Access Industries and Blavatnik Family Foundation

Young scientists represent the future of scientific thought. By honoring these young individuals and their achievements we are helping to promote the breakthroughs in science and technology that will define how our world will look in 20, 50, 100 years.

Ethel Romm

I do more than support them, I have an annuity—I made the Academy a beneficiary…There are a lot of places that need your money, but the Academy should be at the top of your list. Why? Because there aren’t a lot of places that are thinking all the time, where there aren’t political agendas, religious agendas, etc. And they bring people together around science.

Joel and Liora Kirman

Two parents and their adult daughter all pose together, with the NYC skyline in the background.

To us, it is a heaven-sent method of supporting the upcoming and current practitioners of science and technology as they work to make the world a better place.

Carolyn J. Foster, PhD

A couple pose together and smile for the camera.

I support the Academy so that young scientists can have the same nurturing environment I enjoyed, so that they can see new opportunities and meet people from all aspects of STEM.

Jennifer Henry, PhD

The Academy continually evolves to provide unique resources and opportunities for current and future scientists worldwide, which is why I have chosen to support them with a gift from my estate.

Changing the Game: Fighting Alzheimer’s Disease

Inspired by his mother-in-law’s courageous, but heartbreaking battle, George Vradenburg has teamed up with the Academy to take on Alzheimer’s disease.

Published August 1, 2013

By Noah Rosenberg
Academy Contributor

A 3D-rendered medically accurate illustration of amyloid plaques on a nerve cell (Alzheimer’s disease). Image courtesy of Sebastian Kaulitzki via stock.adobe.com.

George Vradenburg’s resume reads like a roadmap to prototypical business success. He was Phi Beta Kappa in college and attended Harvard Law School. He later co-published a magazine and brokered deals for media giants like CBS, Fox, and AOL, founding two charities in his spare time. George Vradenburg, to be sure, is a man who seized his life and career by the horns.

But then it all changed. In the early ’90s, as his mother-in-law faded with Alzheimer’s disease, Vradenburg could only sit back idly, helplessly. “I saw the progress from paranoia to hallucinations to falls to institutionalization to the late stage where she was physically immobile and totally unaware of her surroundings and her family,” Vradenburg remembers. “It is not a long goodbye, not the romanticized long farewell. It is a horrid disease.”

Of course, Vradenburg and his family weren’t alone. Today, 36 million people struggle with the disease worldwide, and that number is expected to grow to 115 million by 2050. So Vradenburg was shocked to realize that Alzheimer’s research and treatment had long been stagnant, frozen in a frustrating holding pattern.

True to form, Vradenburg decided he needed to do something about it. He enlisted his screenwriter wife to develop plays about her mother’s battle with Alzheimer’s, but it didn’t take Vradenburg long to understand that the level of zeal he brought to bear on curbing the disease was practically unparalleled.

“I thought, ‘Why in the heck is there not a national strategic plan on this?’” Vradenburg recalls, still incredulous. “I was frustrated by the absence of urgency and passion. Everyone seemed to be conducting business as usual.”

Taking Action

Vradenburg set out to change the nature of the game. He partnered with the Alzheimer’s Association and, for eight years, put on an Alzheimer’s fundraising gala. From there, he formed a political action committee, an Alzheimer’s study group, and, in 2010, co-founded USAgainstAlzheimer’s, an education and advocacy campaign for which he still serves as chairman.

And now, nearly two decades after his mother-in-law’s death, Vradenburg’s Global CEO Initiative—a newly-formed private-sector committee designed to collaborate with the public sector, non-profit community, and academia—has joined forces with The New York Academy of Sciences in a next-generation, cross-industry collaboration, called the Alzheimer’s Disease and Dementia Initiative (ADDI), that will attempt to effectively combat the disease once and for all.

The CEO Initiative’s goals, after all, are directly aligned with the Academy’s own efforts. Launched in 2011, the aim of the ADDI is the translation of basic research about disease mechanisms into the development of new methods for diagnosis, treatment, and prevention of Alzheimer’s disease and dementia. The Academy developed a Leadership Council of multi-sector stakeholders—academic researchers, industry scientists, patient advocates, and government and foundation representatives—to define priorities and develop action steps for progress in Alzheimer’s diagnosis, treatment, and prevention.

Creating an Agenda

The Holy Grail for the ADDI is the development and implementation of a comprehensive research agenda aimed at preventing and treating Alzheimer’s by 2025. It is a bold, ambitious, and lofty goal—Vradenburg is the first to admit that.

But, he says, “I can’t be giving up. You have to continue to push ahead no matter how many failures there are.”

And so Vradenburg decided to support the ADDI and, in turn, the many multi-sector experts comprising the collaborative working group that dedicates its time and expertise to define key action items around big challenges: gaining a better understanding of the pathophysiology of Alzheimer’s; developing innovative therapeutic approaches and strategies to engage patients in clinical trials; decreasing the time, cost, and risk of drug development; and increasing funding models, such as public-private co-investment, social impact investment, and new public funding mechanisms.

The CEO Initiative generously seeded its partnership with the Academy with a contribution of $325,000. Academy President and CEO Ellis Rubinstein considers the gift “a testament to the power of the partnerships being facilitated by The New York Academy of Sciences.”

“George is a visionary who realizes that the complexity of the grand challenges confronting humanity can only be addressed efficiently through alliance-building,” Rubinstein says. “For this reason, we at the Academy regard George as a role model for budding philanthropists: he uses his resources not for self-aggrandizement but to catalyze collective action.”

The Path to 2025

The joint research agenda, to be developed by the Academy and the CEO Initiative by late summer 2013, is simply the beginning. The working group’s results will feed into the Academy’s upcoming conference, “Alzheimer’s Disease Summit: The Path to 2025,” to be held on November 6 and 7 at its Lower Manhattan headquarters.

The gathering will build on the work of the National Institutes of Health’s biennial Alzheimer’s Disease Research Summit and, according to the Academy, “advance a research agenda that is informed by the needs, experience, perspectives, and lessons learned from industry, academic, and government research efforts.”

Following the November summit, the working group will produce a meta-analysis, including long-term plans for patient engagement in clinical trials, preventative measures, and future coordination efforts.

Not one to chase progress timidly, Vradenburg cautions that the Academy and the CEO Initiative must use the fall Alzheimer’s Summit “not as a conversation but actually an action-driver. We need to use it as a deadline for taking certain steps.” To that end, he explains that the working group is expecting to reveal breakthroughs in the area of biomarkers, data-sharing, clinical trial recruitment, and innovative financing mechanisms during the summit.

Synergies Across Organizations

Vradenburg sees his partnership with the Academy as the logical path forward between two organizations whose objectives, and even personnel, have overlapped in the past.

“What intrigued me about the Academy was their reach—into academia and geographically,” he says, commending the Academy’s visionary leadership. “They have a reputation for taking on challenging issues. They have the same spirit of innovation and drive that I think I have, so there’s been sort of a mind meld at the leadership level.”

The feeling is mutual. “George brings an incredible energy to all of his endeavors,” says Academy Executive Vice President and COO Michael Goldrich, “which, combined with his formidable business acumen, makes him a person who gets results.”

A Critical Time

On top of that, the ADDI is embarking at perhaps the optimal time in the war against Alzheimer’s. This year, for instance, President Obama mentioned the importance of Alzheimer’s research in his State of the Union address—a sign of what Vradenburg calls a “significant uptick” in government attention to the disease. As a result, there has been “enormous progress” in research, he says, notably in the area of enhanced imaging techniques that allow for the detection of the disease up to 20 years before symptoms appear.

Progress, however, has been largely one-sided. “On the treatment side,” Vradenburg laments, “there have been zero advances.” This leads to a cruel reality in which patients might learn of their fate decades before it sets in, and with no way to prevent the disease’s onset.

“It’s frustrating for the patient population out there,” Vradenburg stresses. “They get treated with the wrong drugs; they’re wrongly diagnosed and mistreated at earlier stages.”

“And there’s also the second-hand victims, the caregivers,” he adds. “People are going bankrupt or having to quit work or delay college to care for their loved ones. There’s an emotional, physical, health, and financial impact of this disease on families around the world today.”

Exceeds $600 Billion Worldwide

In fact, the annual burden of caring for the current number of Alzheimer’s patients and those with related dementia exceeds $600 billion worldwide and will only continue to grow in the absence of meaningful innovation.

Vradenburg is aware, though, that success doesn’t come easy. He explains that the ADDI is pushing to introduce first-generation disease-modifying treatment into the marketplace by 2020 and to foster a means of prevention and effective treatment in the marketplace by 2025, as well as to develop the critical intervention methods to get treatment into the hands of at-risk populations.

“All of my efforts,” he emphasizes, “have basically challenged people to identify the critical hurdles that would change the trajectory and speed, the velocity and volume of what we’re doing. I’ve always got to be optimistic,” Vradenburg says.

Also read: Resolving Neuro-Inflammation to Treat Alzheimer’s Disease and Pain


About the Author

Noah Rosenberg is a freelance journalist in New York City.